DBV Technologies | Despesas De Vendas E Administração



Selling And Administration Expenses Alterar Data
Acadia Pharmaceuticals USD 130.08M 3.21M 2024-12
Alnylam Pharmaceuticals USD 239.95M 55.39M 2025-03
Amarin USD 36.9M 1.64M 2024-09
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
DBV Technologies USD 6.24M 1.32M 2024-09
Halozyme Therapeutics USD 42.36M 113K 2025-03
Incyte USD 325.69M 1.02M 2025-03
Insmed USD 142.51M 23.58M 2024-12
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
Neurocrine Biosciences USD 287.8M 53.5M 2024-12
PTC Therapeutics USD 161.92M 77.24M 2025-03
Sarepta Therapeutics USD 133.63M 30.24M 2025-03
Ultragenyx Pharmaceutical USD 87.8M 5.3M 2025-03
United Therapeutics USD 170.1M 7.6M 2025-03



DBV Technologies Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.